Interpace Biosciences, Inc. (IDXGD)
7.618
+0.37
(+5.08%)
USD |
OTCM |
Aug 28, 16:00
Interpace Biosciences Market Cap : 42.21M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 42.21M |
| August 26, 2026 | 40.17M |
| August 25, 2026 | 39.34M |
| August 24, 2026 | 39.61M |
| August 21, 2026 | 210.91M |
| August 20, 2026 | 222.99M |
| August 19, 2026 | 217.45M |
| August 18, 2026 | 221.61M |
| August 17, 2026 | 235.46M |
| August 14, 2026 | 229.92M |
| August 13, 2026 | 231.30M |
| August 12, 2026 | 231.30M |
| August 11, 2026 | 231.16M |
| August 10, 2026 | 235.46M |
| August 07, 2026 | 222.99M |
| August 06, 2026 | 227.15M |
| August 05, 2026 | 207.41M |
| August 04, 2026 | 225.76M |
| August 03, 2026 | 220.22M |
| July 31, 2026 | 210.11M |
| July 30, 2026 | 199.45M |
| July 29, 2026 | 214.92M |
| July 28, 2026 | 215.03M |
| July 27, 2026 | 213.93M |
| July 24, 2026 | 202.22M |
| Date | Value |
|---|---|
| July 23, 2026 | 200.83M |
| July 22, 2026 | 209.14M |
| July 21, 2026 | 208.37M |
| July 20, 2026 | 206.37M |
| July 17, 2026 | 211.22M |
| July 16, 2026 | 214.68M |
| July 15, 2026 | 224.38M |
| July 14, 2026 | 224.38M |
| July 13, 2026 | 207.76M |
| July 10, 2026 | 227.15M |
| July 09, 2026 | 226.89M |
| July 08, 2026 | 225.07M |
| July 07, 2026 | 227.84M |
| July 06, 2026 | 228.53M |
| July 02, 2026 | 225.76M |
| July 01, 2026 | 222.99M |
| June 30, 2026 | 225.76M |
| June 29, 2026 | 232.69M |
| June 26, 2026 | 228.53M |
| June 25, 2026 | 227.15M |
| June 24, 2026 | 235.46M |
| June 23, 2026 | 232.69M |
| June 22, 2026 | 225.76M |
| June 18, 2026 | 230.89M |
| June 17, 2026 | 227.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 4.766M |
| Vivos Therapeutics, Inc. | 3.268M |
| Hinge Health, Inc. | 7.006B |
| PD-Rx Pharmaceuticals, Inc. | 5.099M |
Market Cap Related Metrics
| PE Ratio | 1.727 |
| PS Ratio | 1.168 |
| PEG Ratio | 0.0397 |
| Price to Book Value | 1.816 |
| Price to Free Cash Flow | 10.29 |
| Price | 7.618 |
| Earnings Yield | 57.91% |
| PEGY Ratio | 0.0397 |
| Operating PE Ratio | 10.13 |
| Normalized PE Ratio | 1.732 |